Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia

被引：2

作者：

Richardson, Kris ^{[1
,2
]}

Castillo, Jorge J. ^{[1
,2
]}

Sarosiek, Shayna R. ^{[1
,2
]}

Branagan, Andrew R. ^{[2
,3
]}

Flynn, Catherine A. ^{[1
]}

Meid, Kirsten ^{[1
]}

Gustine, Joshua N. ^{[2
,3
]}

Liu, Xia ^{[1
,2
]}

Kofides, Amanda ^{[1
]}

Liu, Shirong ^{[1
,2
]}

Wolf, Julie L. ^{[4
]}

Kacena, Katherine A. ^{[5
]}

Patterson, Christopher J. ^{[1
]}

Guerrera, Maria Luisa ^{[1
,2
]}

Tsakmaklis, Nicholas ^{[1
]}

Treon, Steven P. ^{[1
,2
]}

Hunter, Zachary R. ^{[1
,2
]}

机构：

[1] Dana Farber Canc Inst, Bing Ctr Waldenstroms Macroglobulinemia, SM630,450 Brookline Ave, Boston, MA 02115 USA

[2] Harvard Med Sch, Dept Med, Boston, MA USA

[3] Massachusetts Gen Hosp, MGH Canc Ctr, Boston, MA USA

[4] Wolf Biostat, Boston, MA USA

[5] BioBridges, Boston, MA USA

来源：

BLOOD ADVANCES | 2024年 / 8卷 / 09期

基金：

美国国家卫生研究院;

关键词：

WALDENSTROM MACROGLOBULINEMIA; RESISTANCE; MUTATIONS; SURVIVAL; MYD88; ZANUBRUTINIB; DETERMINANT; ERK1/2; CELLS;

D O I：

10.1182/bloodadvances.2023012111

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2133 / 2137

页数：5

共 24 条

[1] The WHIM-like CXCR4S338X somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's Macroglobulinemia [J].

Cao, Y. ;

Hunter, Z. R. ;

Liu, X. ;

Xu, L. ;

Yang, G. ;

Chen, J. ;

Patterson, C. J. ;

Tsakmaklis, N. ;

Kanan, S. ;

Rodig, S. ;

Castillo, J. J. ;

Treon, S. P. .

LEUKEMIA, 2015, 29 (01) :169-176

[2] CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88L265P-directed survival signalling in Waldenstrom macroglobulinaemia cells [J].

Cao, Yang ;

Hunter, Zachary R. ;

Liu, Xia ;

Xu, Lian ;

Yang, Guang ;

Chen, Jie ;

Tsakmaklis, Nickolas ;

Kanan, Sandra ;

Castillo, Jorge J. ;

Treon, Steven P. .

BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (05) :701-707

[3] Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia [J].

Castillo, Jorge J. ;

Meid, Kirsten ;

Gustine, Joshua N. ;

Leventoff, Carly ;

White, Timothy ;

Flynn, Catherine A. ;

Sarosiek, Shayna ;

Demos, Maria G. ;

Guerrera, Maria L. ;

Kofides, Amanda ;

Liu, Xia ;

Munshi, Manit ;

Tsakmaklis, Nicholas ;

Xu, Lian ;

Yang, Guang ;

Branagan, Andrew R. ;

O'Donnell, Elizabeth ;

Raje, Noopur ;

Yee, Andrew J. ;

Patterson, Christopher J. ;

Hunter, Zachary R. ;

Treon, Steven P. .

LEUKEMIA, 2022, 36 (02) :532-539

[4] Partial response or better at six months is prognostic of superior progression-free survival in Waldenstrom macroglobulinaemia patients treated with ibrutinib [J].

Castillo, Jorge J. ;

Abeykoon, Jithma P. ;

Gustine, Joshua N. ;

Zanwar, Saurabh ;

Mein, Kirsten ;

Flynn, Catherine A. ;

Demos, Maria G. ;

Guerrera, Maria L. ;

Kofides, Amanda ;

Liu, Xia ;

Munshi, Manit ;

Tsakmaklis, Nickolas ;

King, Rebecca ;

Yang, Guang ;

Hunter, Zachary R. ;

Advani, Ranjana H. ;

Palomba, Maria Lia ;

Ansell, Stephen M. ;

Gertz, Morie A. ;

Kapoor, Prashant ;

Treon, Steven P. .

BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (03) :542-550

[5] CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenstrom macroglobulinaemia treated with ibrutinib [J].

Castillo, Jorge J. ;

Xu, Lian ;

Gustine, Joshua N. ;

Keezer, Andrew ;

Meid, Kirsten ;

Dubeau, Toni E. ;

Liu, Xia ;

Demos, Maria G. ;

Kofides, Amanda ;

Tsakmaklis, Nicholas ;

Chen, Jiaji G. ;

Munshi, Manit ;

Guerrera, Maria L. ;

Chan, Gloria G. ;

Patterson, Christopher J. ;

Yang, Guang ;

Hunter, Zachary R. ;

Treon, Steven P. .

BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (03) :356-363

[6] BTKCys481Ser drives ibrutinib resistance via ERK1/2 and protects BTKwild-type MYD88-mutated cells by a paracrine mechanism [J].

Chen, Jiaji G. ;

Liu, Xia ;

Munshi, Manit ;

Xu, Lian ;

Tsakmaklis, Nicholas ;

Demos, Maria G. ;

Kofides, Amanda ;

Guerrera, Maria Luisa ;

Chan, Gloria G. ;

Patterson, Christopher J. ;

Meid, Kirsten ;

Gustine, Joshua ;

Dubeau, Toni ;

Severns, Patricia ;

Castillo, Jorge J. ;

Hunter, Zachary R. ;

Wang, Jinhua ;

Buhrlage, Sara J. ;

Gray, Nathanael S. ;

Treon, Steven P. ;

Yang, Guang .

BLOOD, 2018, 131 (18) :2047-2059

[7] G protein-coupled estrogen receptor 1 (GPER1)/GPR30 increases ERK1/2 activity through PDZ motif-dependent and -independent mechanisms [J].

de Valdivia, Ernesto Gonzalez ;

Broselid, Stefan ;

Kahn, Robin ;

Olde, Bjorn ;

Leeb-Lundberg, L. M. Fredrik .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (24) :9932-9943

[8] Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study [J].

Dimopoulos, Meletios A. ;

Opat, Stephen ;

D'Sa, Shirley ;

Jurczak, Wojciech ;

Lee, Hui-Peng ;

Cull, Gavin ;

Owen, Roger G. ;

Marlton, Paula ;

Wahlin, Bjoern E. ;

Garcia-Sanz, Ramon ;

McCarthy, Helen ;

Mulligan, Stephen ;

Tedeschi, Alessandra ;

Castillo, Jorge J. ;

Czyz, Jaroslaw ;

de Larrea, Carlos Fernandez ;

Belada, David ;

Libby, Edward ;

Matous, Jeffrey ;

Motta, Marina ;

Siddiqi, Tanya ;

Tani, Monica ;

Trneny, Marek ;

Minnema, Monique C. ;

Buske, Christian ;

Leblond, Veronique ;

Treon, Steven P. ;

Trotman, Judith ;

Chan, Wai Y. ;

Schneider, Jingjing ;

Allewelt, Heather ;

Patel, Sheel ;

Cohen, Aileen ;

Tam, Constantine S. .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (33) :5099-+

[9] GPR18 undergoes a high degree of constitutive trafficking but is unresponsive to N-Arachidonoyl Glycine [J].

Finlay, David B. ;

Joseph, Wayne R. ;

Grimsey, Natasha L. ;

Glass, Michelle .

PEERJ, 2016, 4

[10] Regularization Paths for Generalized Linear Models via Coordinate Descent [J].

Friedman, Jerome ;

Hastie, Trevor ;

Tibshirani, Rob .

JOURNAL OF STATISTICAL SOFTWARE, 2010, 33 (01) :1-22

← 1 2 3 →